Quadros Bio

Where Soil Science Meets Investment Intelligence

Capital allocated with rigor.

Soils restored with evidence.

Products that perform in the field.

Our Services

Science-Based Risk Intelligence
for High-Stakes Decisions

01

Bio Investment
Intelligence

Technical validation of startup claims before you write the check

QBIView™ (Quadros Bio Investment View) Technology Assessments reveal that most biological claims fail rigorous scrutiny. Even those that pass initial evaluations often fall short in the field, after the money has been spent. Our structured, evidence-based framework covers seven analytical dimensions: biological validity, field translation probability, regulatory pathway, and team scientific depth, giving you the insight to decide whether to invest and how to structure it.

02

Quadros Bio
Brazilian Network

Bridging Brazilian innovation with North American opportunity

Brazil leads the world in commercial agricultural biologicals, backed by a robust public-sector research and field trial infrastructure that most North American investors are unaware of. Quadros Bio Inc.'s expert network maintains active research relationships across Brazil's federal university system and Embrapa, giving us early visibility into promising technologies, emerging talent, and business opportunities before they reach the North American radar.

03

Plant-Microbe-Environment
System

Tailored field trial design that tests biologicals in the system where they actually have to work

Biological product performance depends on three interacting systems: the plant, its microbial community, and the soil-climate environment around them. Quadros Bio designs and reviews field trial programs that account for all three across agroecological zones, microbial compatibility, application timing, and environmental variability. The result is trial data that holds up under regulatory review and predicts commercial performance in the field, not just statistical significance in a single plot.

The Brazilian Network

Brazil is a biologicals powerhouse. We help North America understand it, and Brazilian innovators cross the bridge.

On the Spot: featured profiles

Sample data
QBIView Screened

Example Company A

Biological nitrogen fixation

On the Spot

Example Company B

Biostimulants

QBIView Market-Ready

Example Company C

Biocontrol

Why Quadros Bio

Closing the Gap Between Biological Innovation, Field Performance, and Market Success

Validation Infrastructure for the Agricultural Biologicals Pathway: Ready Products for Farmers · Healing Soils · Capital That Funds What Really Works

Why Investors and Strategic Partners Choose Quadros Bio Inc.

Rooted in World-Class Research Institutions

Dr. Patrícia Dörr de Quadros brings two decades of soil microbiology research, with a sandwich doctorate split between UFRGS (Brazil) and the University of Florida, and postdoctoral work at UFRGS, the University of Toronto, and the University of Waterloo. Her academic lineage runs through Embrapa, CBMAI at UNICAMP, UFRGS, and UFSC, with seventeen-plus years of research experience, 38-plus peer-reviewed publications, and direct commercial experience across three prior biologicals ventures. This depth is the backbone of every assessment Quadros Bio delivers.

Network of Experts

A curated network of specialists in soil microbiology, regulatory affairs, agricultural IP, fermentation science, and field agronomy, assembled per engagement, not kept on retainer. The right expertise for your specific question, every time.

Pattern Recognition

We know where biological technologies fail, not from models or literature alone, but from years of direct involvement in product development and commercialization across multiple continents. That accumulated experience allows Quadros Bio to ask the questions that matter most, and to recognize a miscalculated pathway before it becomes a financial event.

Cross-Border Intelligence

Brazil produces more registered biological products than any other market, backed by deeper public-sector research and field trial infrastructure. Most North American investors encounter these innovations only after valuations have climbed. Quadros Bio gets you there first.

Confidential by default. Not sold. Not published. Not shared without permission.

Row-level data security

Versioned consent and methodology

Independent expert review

Verifiable QBIView badges

Get Started

Make better biologicals decisions before the risk is already priced in.

Pick the path that matches your moment, or send a message.

Send a message

We respond within two business days.

We respond within two business days. Confidential by default.

Prefer email? patricia.quadros@quadrosbio.com